
Metabolic Disorders
Bone loss at lumbar spine after kidney transplant reduced with IV pamidronate
Osteoporos Int. 2011 Jan;22(1):281-739 patients with ostepenia and who underwent a kidney transplant were enrolled in this study to determine if the administration of intravenous pamidronate postoperatively improved bone mineral density (BMD). BMD, skeletal fractures and bone remodeling were analyzed one year after the transplant to evaluate the effects of intravenous bisphophonates. Patients who received the pamidronate demonstrated maintained lumbar spine bone mineral density compared to a decrease in those who received placebo, the differences being significant between groups over 12 months postoperatively. At 12 months, the pamidronate group demonstrated a 1% increase in lumbar spine BMD, compared to a -6% decrease in the placebo group. No significant differences between groups were noted in femoral neck or total hip BMD, however.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.